Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers. Letsch M, Schally AV, Busto R, Bajo AM, Varga JL, Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA - Proc Natl Acad Sci USA 2003;100:1250-1255

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 411-412

Elsevier

Access to resources Recommend Favorite

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? - Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW, Division of General Internal Medicine, University of Texas-Houston Medical School, Houston, TX. Am J Public Health 2003;93:779-785

By Carroll P.R.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 484-484

Elsevier

Access to resources Recommend Favorite

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX - Cancer 2003;97:561-567

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 412-412

Elsevier

Access to resources Recommend Favorite

Molecular and cellular biology of prostate cancer

By Lalani E-N.  

Cancer and Metastasis Reviews, Vol. 16, Iss. 1-2, 1997-06 ,pp. : 29-66

Springer Publishing Company

Access to resources Recommend Favorite

The crossroads of prostate cancer and thermal medicine

By Hurwitz Mark  

International Journal of Hyperthermia, Vol. 26, Iss. 8, 2010-12 ,pp. : 735-736

Informa Healthcare

Access to resources Recommend Favorite